Mariani, John N.
Mansky, Benjamin
Madsen, Pernille M.
Salinas, Dennis
Kesmen, Deniz
Huynh, Nguyen P. T.
Kuypers, Nicholas J.
Kesel, Erin R.
Bates, Janna
Payne, Casey
Chandler-Militello, Devin
Benraiss, Abdellatif
Goldman, Steven A. https://orcid.org/0000-0002-5498-4303
Funding for this research was provided by:
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
U.S. Department of Health & Human Services | National Institutes of Health (R01AG072298)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS110776)
Novo Nordisk Fonden
Article History
Received: 20 May 2023
Accepted: 18 April 2024
First Online: 8 May 2024
Competing interests
: Dr. Goldman is also a part-time employee and stockholder of Sana Biotechnology (Seattle, WA), and his lab receives sponsored research support for projects unrelated to the present work from Sana. Dr. Goldman is also a stockholder and SAB member of CNS2, Inc.; his lab also receives research support from CNS2. N.P.T.H is now a Sana employee, and D.C.M. is a consultant to Sana, in both cases for unrelated work. None of the other authors have any known potential conflicts of interest with regards to this work.